Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer
Open Access
- 2 November 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Abstract
Digital analysis of pathology whole-slide images is fast becoming a game changer in cancer diagnosis and treatment. Specifically, deep learning methods have shown great potential to support pathology analysis, with recent studies identifying molecular traits that were not previously recognized in pathology H&E whole-slide images. Simultaneous to these developments, it is becoming increasingly evident that tumor heterogeneity is an important determinant of cancer prognosis and susceptibility to treatment, and should therefore play a role in the evolving practices of matching treatment protocols to patients. State of the art diagnostic procedures, however, do not provide automated methods for characterizing and/or quantifying tumor heterogeneity, certainly not in a spatial context. Further, existing methods for analyzing pathology whole-slide images from bulk measurements require many training samples and complex pipelines. Our work addresses these two challenges. First, we train deep learning models to spatially resolve bulk mRNA and miRNA expression levels on pathology whole-slide images (WSIs). Our models reach up to 0.95 AUC on held-out test sets from two cancer cohorts using a simple training pipeline and a small number of training samples. Using the inferred gene expression levels, we further develop a method to spatially characterize tumor heterogeneity. Specifically, we produce tumor molecular cartographies and heterogeneity maps of WSIs and formulate a heterogeneity index (HTI) that quantifies the level of heterogeneity within these maps. Applying our methods to breast and lung cancer slides, we show a significant statistical link between heterogeneity and survival. Our methods potentially open a new and accessible approach to investigating tumor heterogeneity and other spatial molecular properties and their link to clinical characteristics, including treatment susceptibility and survival.Keywords
All Related Versions
This publication has 69 references indexed in Scilit:
- THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing dataGenome Biology, 2013
- A Comprehensive Survey of Ras Mutations in CancerCancer Research, 2012
- Identifying microRNA/mRNA dysregulations in ovarian cancerBMC Research Notes, 2012
- Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to TrastuzumabJapanese Journal of Clinical Oncology, 2011
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast TumorsPLOS ONE, 2011
- miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1Breast Cancer Research and Treatment, 2010
- CD24: from A to ZCellular & Molecular Immunology, 2010
- Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer TypesPLOS ONE, 2009
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- Mir-17-5pRegulates Breast Cancer Cell Proliferation by Inhibiting Translation ofAIB1mRNAMolecular and Cellular Biology, 2006